Alzheimer disease: Quantitative H-1 MR spectroscopic imaging of frontoparietal brain

Radiology

Volumn 207, Issue 1, 1998, Pages 91-102

  Schuff, Norbert ^a   Amend, Diane L ^a   Meyerhoff, Dieter J ^a   Tanabe, Jody L ^a   Norman, David ^a   Fein, George ^a   Weiner, Michael W ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Brain, diseases; Brain, metabolism; Brain, MR; Dementia; Magnetic resonance (MR), spectroscopy

Indexed keywords

CHOLINE; N ACETYLASPARTIC ACID;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; FEMALE; FRONTAL CORTEX; HUMAN; IMAGE ANALYSIS; IMAGE RECONSTRUCTION; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARIETAL LOBE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE DIAGNOSIS;

EID: 0031982340     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.207.1.9530304     Document Type: Article

References (37)

1. Jernigan TL, Salmon DP, Butters N, Hesselink JR. Cerebral structure on MRI. II. Specific changes in Alzheimer's and Huntington's diseases. Biol Psychiatry 1991; 29:68-81.
2. Luxenberg JS, Haxby JV, Creasey H, Sundaram M, Rapoport SI. Rate of ventricular enlargement in dementia of the Alzheimer type correlates with rate of neuropsychological deterioration. Neurology 1987; 37:1135-1140.
3. Tanabe J, Amend D, Schuff N, et al. Tissue segmentation of the brain in Alzheimer's disease. AJNR 1997; 18:115-123.
4. Kesslak JP, Nalcioglu O, Cotman CW. Quantification of magnetic resonance scans for hippocampal and parahippocampal atrophy in Alzheimer's disease. Neurology 1991; 41:51-54.
5. Jagust WJ. Functional imaging patterns in Alzheimer's disease: relationships to neurobiology. Ann NY Acad Sci 1996; 777:30-36.
6. Terry RD, Peck A, DeTeresa R, Schlechter R, Horoupian DS. Some morphometric aspects of the brain in senile dementia of the Alzheimer type. Ann Neurol 1981; 10:184-192.
7. Urenjak J, Williams SR, Gadian DG, Noble M. Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro. J Neurochem 1992; 59:55-61.
8. Meyerhoff DJ, MacKay S, Constans JM, et al. Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging. Ann Neurol 1994; 36: 40-47.
9. MacKay S, Meyerhoff DJ, Constans JM, Norman D, Fein G, Weiner MW. Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H magnetic resonance spectroscopic imaging. Arch Neurol 1996; 53:167-174.
10. MacKay S, Ezekiel F, Di Sclafani V, et al. Alzheimer disease and subcortical ischemic vascular dementia: evaluation by combining MR imaging segmentation and H-1 MR spectroscopic imaging. Radiology 1996; 198:537-545.
11. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34:939-944.
12. Folstein MF, Folstein SE, McHugh PR. Mini-mental state: a practical method for grading cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198.
13. Maudsley AA, Matson GB, Hugg JW, Weiner MW. Reduced phase encoding in spectroscopic imaging. Magn Reson Med 1994; 31:645-651.
14. Maudsley AA, Lin E, Weiner MW. Spectroscopic imaging display and analysis. Magn Reson Imaging 1992; 10:471-485.
15. Moats RA, Ernst T, Shonk TK, Ross BD. Abnormal cerebral metabolite concentrations in patients with probable Alzheimer disease. Magn Reson Med 1994; 32:110-115.
16. Christiansen P, Schlosser A, Henriksen O. Reduced N-acetylaspartate content in the frontal part of the brain in patients with probable Alzheimer's disease. Magn Reson Imaging 1995; 13:457-462.
17. Birken DL, Oldendorf WH. N-acetylaspartic acid. Neurosci Biobehav Rev 1989; 13:23-31.
18. De Stefano N, Matthews PM, Arnold DL. Reversible decreases in N-acetylaspartate after acute brain injury. Magn Reson Med 1995; 34:721-727.
19. Block W, Traeber F, Kuhl CK, et al. 1H-MR spectroscopic imaging in patients with clinically diagnosed Alzheimer's disease. ROFO 1995; 163:230-237.
20. Ernst T, Chang L, Melchor R, Mehringer CM. Frontotemporal dementia and early Alzheimer disease: differentiation with frontal lobe H-1 MR spectroscopy. Radiology 1997; 203:829-836.
21. 1H MR spectroscopy: correlation with disease severity (abstr). In: Proceedings of the Fifth Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 1997; 298.
22. Strittmatter WJ, Roses AD. Apolipoprotein E and Alzheimer's disease. Ann Rev Neurosci 1996, 19:53-77.
23. Nitsch R, Pittas A, Blusztajn JK, Slack BE, Growdon JH, Wurtman RJ. Alterations of phospholipid metabolites in postmortem brain from patients with Alzheimer's disease. Ann NY Acad Sci 1991; 640:110-113.
24. 1H spectroscopic imaging of human brain at 4.1-T using image segmentation. Magn Reson Med 1996; 36:21-29.
25. Lim KO, Spielman DM. Estimating NAA in cortical gray matter with applications for measuring changes due to aging. Magn Reson Med 1997; 37:372-377.
26. Constans JM, Meyerhoff DJ, Gerson J, et al. H-1 MR spectroscopic imaging of white matter signal hyperintensities: Alzheimer disease and ischemic vascular dementia. Radiology 1995; 197:517-523.
27. Ende G, Laxer K, Knowlton RC, et al. Temporal lobe epilepsy: bilateral hippocampal metabolite changes revealed at proton MR spectroscopic imaging. Radiology 1997; 202:809-818.
28. Schuff N, Amend D, Ezekiel F, et al. Changes of hippocampal N-acetyl aspartate and volume in Alzheimer's disease: a proton MR spectroscopic imaging and MRI study. Neurology 1997; 49:1513-1521.
29. 1H MR spectroscopic imaging (abstr). In: Proceedings of the Fourth Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 1996; 1213.
30. Duyn JH, Gillen J, Sobering G, van Zijl PC, Moonen CT. Multisection proton MR spectroscopic imaging of the brain. Radiology 1993; 188:277-282.
31. Hetherington H, Mason GF, Pan JW, et al. Evaluation of cerebral gray and white matter metabolite differences by spectroscopic imaging at 4.1T. Magn Reson Med 1994; 33:565-571.
32. Tedeschi G, Bertolino A, Lundborn N, et al. Cortical and subcortical chemical pathology in Alzheimer's disease as assessed by multislice proton magnetic resonance spectroscopic imaging. Neurology 1996; 47:696-704.
33. Miller BL, Moats RA, Shonk T, Ernst T, Woolley S, Ross BD. Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy. Radiology 1993; 187:433-437.
34. Bruhn H, Weber T, Thorwirth V, Frahm J. In-vivo monitoring of neuronal loss in Creutzfeldt-Jakob disease by proton magnetic resonance spectroscopy (letter). Lancet 1991; 337:1610-1611.
35. Shonk TK, Moats RA, Gifford P, et al. Probable Alzheimer disease: diagnosis with proton MR spectroscopy. Radiology 1995; 195:65-72.
36. Posse S, Schuknecht B, Smith ME, et al. Short echo time proton MR spectroscopic imaging. J Comput Assist Tomogr 1993; 17:1-14.
37. Tanabe J, Ezekiel F, Jagust WJ, Schuff N, Fein G. A volumetric method for evaluating magnetization transfer ratio of tissue categories: application to white matter signal hyperintensities in the elderly. Radiology 1997; 204:570-575.